Laupacis A. Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply. J Popl Ther Clin Pharmacol [Internet]. 2018 Dec. 8 [cited 2024 Nov. 19];16(2). Available from: https://mail.jptcp.com/index.php/jptcp/article/view/557